|
ZNF839 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.70260000332112E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.14180001406805E-09 |
| Normal-vs-Stage2 |
5.252200E-02 |
| Normal-vs-Stage3 |
1.97330000006879E-07 |
| Normal-vs-Stage4 |
1.048670E-04 |
| Stage1-vs-Stage2 |
4.695600E-02 |
| Stage1-vs-Stage3 |
4.509800E-01 |
| Stage1-vs-Stage4 |
6.593400E-01 |
| Stage2-vs-Stage3 |
1.763790E-02 |
| Stage2-vs-Stage4 |
7.330200E-02 |
| Stage3-vs-Stage4 |
9.824400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.29720001196665E-09 |
| Normal-vs-AfricanAmerican |
1.296390E-01 |
| Normal-vs-Asian |
1.362050E-03 |
| Caucasian-vs-AfricanAmerican |
1.927780E-02 |
| Caucasian-vs-Asian |
5.605500E-02 |
| AfricanAmerican-vs-Asian |
3.947000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.33259999999902E-05 |
| Normal-vs-Female |
4.53490001106616E-09 |
| Male-vs-Female |
2.638200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.41349995544482E-09 |
| Normal-vs-Age(41-60Yrs) |
9.95960000027551E-07 |
| Normal-vs-Age(61-80Yrs) |
1.561350E-04 |
| Normal-vs-Age(81-100Yrs) |
3.182700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.950000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.468000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.091000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.820800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.663000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.059400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.56905999999513E-05 |
| Classical-VS-Follicular |
2.573200E-01 |
| Classical-VS-Other |
5.453000E-01 |
| Classical-VS-Normal |
1.94019999955053E-07 |
| Tall-VS-Follicular |
1.78964999999476E-05 |
| Tall-VS-Other |
1.419850E-01 |
| Tall-VS-Normal |
3.72446518071001E-12 |
| Follicular-VS-Other |
4.086200E-01 |
| Follicular-VS-Normal |
1.520010E-03 |
| Other-VS-Normal |
6.941000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.58230000000459E-05 |
| Normal-vs-N1 |
1.6661599999912E-05 |
| N0-vs-N1 |
1.040640E-01 |
|
|
